Where Are They Now? Carla Casulo, MD
Dr. Carla Casulo is a medical oncologist at the University of Rochester Medical Center.
News
Lymphoma Research Foundation’s 2022 North American Educational Forum on Lymphoma To be Held Virtually
LRF announced today that its premier patient education program, the 2022 North American Educational Forum on Lymphoma, will be held virtually from Friday, October 28th to Sunday, October 30th.
Curiosity in Pursuit of a Cure
LRF grantee Abner Louissaint, MD, PhD has been interested in studying things since he was a child. His inquisitiveness followed him
through his adult years and was a catalyst for his desire to pursue a career in the study of lymphoma.
Patient Perspectives: Dispelling Myths About Clinical Trials
Clinical trials are important for advancing research and can provide patients with access to the most cutting-edge treatments. LRF Associate Director of Support Services and Helpline specialist, Izumi Nakano, answers some common questions about clinical trials to help better understand the process and what to think about when considering enrolling in one.
Endurance Events As a Way to Give Back
The popularity of endurance events, such as marathons, bike races, and triathlons, has risen steadily over the past 25 years—and with an increased interest in health, fitness, and competition amid the pandemic, that number is expected to continue to increase. The Lymphoma Research Foundation (LRF) has seen a similar increase in interest
from its donors.
Read the Latest Issue of Pulse: Spring 2022
Read the Spring 2022 edition of Pulse. This issue of Pulse introduces our 2022 Clinical Investigator Career Development Award (CDA) and Postdoctoral Fellowship and Follicular
Lymphoma Priority Research Grantees.
Lymphoma Research Foundation Awards More Than $5.7 Million in Lymphoma Research
The Lymphoma Research Foundation (LRF) has awarded 29 new research grants totaling more than $5.7 million to scientists working at the world’s leading cancer research institutions.
In Remembrance: Bruce Johnson
Remembering Bruce Johnson.
U.S. Food and Drug Administration Approves CAR T Cell Therapy for Large B-Cell Lymphoma
The U.S. Food and Drug Administration Approves Axicabtagene Ciloeucel (YESCARTA) for Diffuse Large B-Cell Lymphoma On April 1, 2022, the U.S. Food and Drug Administration (FDA) announced it has approved the use of axicabtagene ciloeucel (YESCARTA, Kite, a Gilead Company),…
Read the Latest Issue of Pulse: Winter 2022
Read the Winter 2022 edition of Pulse. This issue of Pulse pays homage to family caregivers and the critical role they play in a patients' journey.